Review: taking Aleve and Dimenhydrinate together


Summary

Drug interactions are reported among people who take Aleve and Dimenhydrinate together. This review analyzes the effectiveness and drug interactions between Aleve and Dimenhydrinate. It is created by eHealthMe based on reports of 132 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Aleve

Aleve has active ingredients of naproxen sodium. It is often used in arthritis. (latest outcomes from Aleve 37,838 users)

Dimenhydrinate

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. (latest outcomes from Dimenhydrinate 1,263 users)

On Sep, 17, 2016

132 people who take Aleve, Dimenhydrinate are studied.


Number of reports submitted per year:

Aleve and Dimenhydrinate drug interactions.

Drug effectiveness over time:

Aleve:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 50.0% - (1 of 2 people)
Dimenhydrinate:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Aleve:
  • female: 25.0% - (2 of 8 people)
  • male: 0.0% - (0 of 0 people)
Dimenhydrinate:
  • female: 28.0% - (2 of 7 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Aleve:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 1 people)
Dimenhydrinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood lactate dehydrogenase increased
  • anorexia
  • asthma
  • disorientation
  • neutropenia
  • febrile neutropenia
  • haemorrhage intracranial
  • osteomyelitis
1 - 6 months:
  • asthma
  • cerebral venous thrombosis
1 - 2 years:
  • diarrhea
5 - 10 years:
  • renal failure acute
  • knee arthroplasty
10+ years:
  • diarrhea
not specified:
  • herpes zoster
  • dysuria
  • intestinal obstruction
  • poor venous access
  • nausea
  • pyrexia
  • multiple sclerosis relapse
  • post herpetic neuralgia
  • vomiting
  • pain

Most common drug interactions by gender *:

female:
  • herpes zoster
  • nausea
  • dysuria
  • poor venous access
  • weight increased
  • neutropenia
  • pain
  • fall
  • intestinal obstruction
  • multiple sclerosis relapse
male:
  • renal tubular necrosis
  • intestinal obstruction
  • pyrexia
  • herpes zoster
  • mobility decreased
  • renal failure
  • vomiting
  • diarrhoea
  • febrile neutropenia
  • haemorrhage intracranial

Most common drug interactions by age *:

10-19:
  • lung neoplasm
  • abdominal pain
  • arthralgia
  • blood osmolarity increased
  • blood potassium decreased
  • blood urea decreased
  • blood urea increased
  • blood uric acid decreased
  • blood uric acid increased
  • cholecystitis chronic
20-29:
  • anorexia
  • disorientation
  • lip oedema
  • loss of consciousness
  • nausea
  • respiratory distress
  • tongue oedema
  • tremor
  • vertigo
  • vomiting
30-39:
  • anuria
  • asthma
  • grand mal convulsion
  • haematuria
  • proteinuria
  • pyuria
  • renal tubular necrosis
  • rhabdomyolysis
  • urinary casts
  • white blood cells urine positive
40-49:
  • neutropenia
  • renal tubular necrosis
  • convulsion
  • dysphagia
  • fall
  • sinus disorder
  • subcutaneous emphysema
  • arthritis
  • blister
  • dizziness
50-59:
  • herpes zoster
  • dysuria
  • poor venous access
  • intestinal obstruction
  • multiple sclerosis relapse
  • post herpetic neuralgia
  • pain
  • weight increased
  • myalgia
  • nausea
60+:
  • renal failure acute
  • pyrexia
  • blood creatinine increased
  • intestinal obstruction
  • dizziness
  • herpes zoster
  • nausea
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Aleve and Dimenhydrinate?

Can you answer these questions?

More questions for: Aleve, Dimenhydrinate

You may be interested in these reviews

More reviews for: Aleve, Dimenhydrinate

On eHealthMe, Aleve (naproxen sodium) is often used to treat arthritis. Dimenhydrinate (dimenhydrinate) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.